Showing 5681-5700 of 8875 for: Cochrane Systematic Reviews Back
- Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants
Cochrane Systematic Reviews, 9-Nov-2011
Rotavirus is a common neonatal nosocomial viral infection and epidemics with the newer P(6)G9 strains have been reported. Local mucosal immunity in the intestine to rotavirus is important in the resolution of infection and protection against subsequent in
- Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants
Cochrane Systematic Reviews, 5-Oct-2011
Rotavirus infection is the most common neonatal nosocomial viral infection. It is a major health problem worldwide. Epidemics with the newer P(6)G9 strains have been reported in neonatal units globally. These strains can cause severe symptoms in most infe
- Oral immunotherapy for milk allergy
Cochrane Systematic Reviews, 16-Oct-2012
The mainstay of treatment of IgE-mediated cow milk allergy (IMCMA) is an avoidance diet, which is especially difficult with a ubiquitous food like milk. Milk oral immunotherapy (MOIT) may be an alternative treatment, through desensitization or induction o
- Oral iron supplements for children in malaria‐endemic areas
Cochrane Systematic Reviews, 27-Feb-2016
Iron-deficiency anaemia is common during childhood. Iron administration has been claimed to increase the risk of malaria.
- Oral isotretinoin for acne
Cochrane Systematic Reviews, 24-Nov-2018
Acne vulgaris, a chronic inflammatory disease of the pilosebaceous unit associated with socialisation and mental health problems, may affect more than 80% of teenagers. Isotretinoin is widely recognised as a very effective treatment for severe acne; howev
- Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
Cochrane Systematic Reviews, 27-Jan-2020
Tofacitinib is an oral Janus kinase (JAK) inhibitor which blocks cytokine signaling involved in the pathogenesis of autoimmune diseases including ulcerative colitis (UC). The etiology of UC is poorly understood, however research suggests the development a
- Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation
Cochrane Systematic Reviews, 2-Nov-2017
Gonadotropins are the most commonly used medications for controlled ovarian stimulation in in vitro fertilisation (IVF). However, they are expensive and invasive, and are associated with the risk of ovarian hyperstimulation syndrome (OHSS). Recent calls f
- Oral methylxanthines for bronchiectasis
Cochrane Systematic Reviews, 24-Apr-2000
Bronchiectasis is characterised by chronic sputum production, bronchial wall dilation, recurrent infection and airflow limitation. Methylxanthines are used in the management of airflow limitation associated with asthma and COPD, where they are also purpor
- Oral misoprostol for induction of labour
Cochrane Systematic Reviews, 13-Jun-2014
Misoprostol is an orally active prostaglandin. In most countries misoprostol is not licensed for labour induction, but its use is common because it is cheap and heat stable.
- Oral morphine for cancer pain
Cochrane Systematic Reviews, 22-Apr-2016
This is the third updated version of a Cochrane review first published in Issue 4, 2003 of The Cochrane Library and first updated in 2007. Morphine has been used for many years to relieve pain. Oral morphine in either immediate release or modified release
- Oral naltrexone maintenance treatment for opioid dependence
Cochrane Systematic Reviews, 13-Apr-2011
Research on clinical application of oral naltrexone agrees on several things. From a pharmacological perspective, naltrexone works. From an applied perspective, the medication compliance and the retention rates are poor.
- Oral non steroid anti-inflammatories for children and adults with bronchiectasis
Cochrane Systematic Reviews, 23-Mar-2009
Bronchiectasis is increasing recognised as a co-morbidity in many respiratory illness. Anti inflammatory drugs may reduce the inflammatory cascade and thus reduce symptoms and slow long term pulmonary decline.
- Oral non‐steroidal anti‐inflammatory drug therapy for lung disease in cystic fibrosis
Cochrane Systematic Reviews, 9-Sep-2019
Progressive lung damage causes most deaths in cystic fibrosis. Non-steroidal anti-inflammatory drugs (such as ibuprofen) may prevent progressive pulmonary deterioration and morbidity in cystic fibrosis. This is an update of a previously published review.
- Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults
Cochrane Systematic Reviews, 12-Jul-2017
Pain is a common symptom with cancer, and 30% to 50% of all people with cancer will experience moderate to severe pain that can have a major negative impact on their quality of life. Non-opioid drugs are commonly used to treat cancer pain, and are recomme
- Oral non‐steroidal anti‐inflammatory drugs (single dose) for perineal pain in the early postpartum period
Cochrane Systematic Reviews, 11-Jan-2021
Many women experience perineal pain after childbirth, especially after having sustained perineal trauma. Perineal pain-management strategies are an important part of postnatal care. Non-steroidal anti-inflammatory drugs (NSAIDs) are a commonly-used type o
- Oral nonsteroidal anti‐inflammatory drugs for fibromyalgia in adults
Cochrane Systematic Reviews, 27-Mar-2017
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the treatment of pain in fibromyalgia, despite being considered not to be effective.
- Oral nonsteroidal anti‐inflammatory drugs for neuropathic pain
Cochrane Systematic Reviews, 5-Oct-2015
Although often considered to be lacking adequate evidence, nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the management of neuropathic pain. Previous surveys found 18% to 47% of affected people reported using NSAIDs specifically for the
- Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury
Cochrane Systematic Reviews, 12-Aug-2020
Acute soft tissue injuries are common and costly. The best drug treatment for such injuries is not certain, although non-steroidal anti-inflammatory drugs (NSAIDs) are often recommended. There is concern about the use of oral opioids for acute pain leadin
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
Cochrane Systematic Reviews, 18-Oct-2004
Hot flushes and night sweats are common symptoms experienced by menopausal women. Hormone therapy (HT), containing oestrogens alone or oestrogens together with progestogens in a cyclic or continuous regimen, is often recommended for their alleviation.
- Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Cochrane Systematic Reviews, 2-Jul-2014
Iron deficiency is a significant cause of deferral in people wishing to donate blood. If iron removed from the body through blood donation is not replaced, then donors may become iron deficient. All donors are screened at each visit for low haemoglobin (H
